Pancreatic Cancer: Drugs

Department of Health written question – answered on 8th December 2014.

Alert me about debates like this

Photo of Rosie Cooper Rosie Cooper Labour, West Lancashire

To ask the Secretary of State for Health, what discussions he has had with NHS England on recognising incremental innovation in pancreatic cancer treatment when assessing medicines for inclusion on the Cancer Drugs Fund.

Photo of George Freeman George Freeman The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health

Decisions on the drugs made available through the Cancer Drugs Fund are a matter for NHS England’s Cancer Drugs Fund panel. We have had no discussions. The standard operating procedures for the Fund, which outline the decision-making process the panel follows is available at:

www.england.nhs.uk/ourwork/pe/cdf/

Such decisions are made by an expert panel of clinicians which also includes patient representation. Additionally the panel will use its expert judgement in making final decisions and will be aware of specific issues relating to current treatment options for a given disease area.

Does this answer the above question?

Yes0 people think so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.